Biotechnology News and Research

RSS

New strategy to create a cheap and rapid COVID-19 test based on isothermal amplification

Russian researchers have developed a strategy to create a cheap and rapid COVID-19 test based on isothermal amplification. According to their publication in Applied Biochemistry and Microbiology, use of this strategy will make it possible to create universal test systems for any of the COVID-19 variants.

29 Dec 2021

Researchers discover antibodies that neutralize omicron and other SARS-CoV-2 variants

An international team of scientists have identified antibodies that neutralize omicron and other SARS-CoV-2 variants. These antibodies target areas of the virus spike protein that remain essentially unchanged as the viruses mutate.

28 Dec 2021

Strains - not species - of gut bacteria may provide better insights into the microbiome

Every day, the billions of bacteria that inhabit your digestive system change; the food you eat, medications you take, and germs you're exposed to make some bacteria flourish more than others.

24 Dec 2021

Ad5-nCoV vaccine safe and effective against symptomatic, severe COVID-19, trials shows

One dose of Ad5-nCoV (Convidecia), a COVID-19 vaccine developed in China, is 57.5% effective against symptomatic COVID-19 and 91.7% effective against severe COVID-19 disease beginning 28 days postvaccination, according to a phase 3 randomized controlled trial published in The Lancet.

23 Dec 2021

Cheap and accessible methods for genome sequencing will help tackle future pandemics

A worldwide consortium of scientists, led by the Earlham Institute and the University of Liverpool in the UK, mark a significant milestone in equipping researchers in low- and middle-income countries (LMICs) with cheap and accessible methods for sequencing large collections of bacterial pathogens - at a cost of less than $10USD per genome.

21 Dec 2021

Study analyzes the role of circular RNA in ALS pathology

Amyotrophic lateral sclerosis, known as ALS, is a neurodegenerative disorder which affects motor neurons. These are the neuronal cells responsible for muscle innervation, whose degenerations leads to progressive paralysis culminating with motor and respiratory failure.

21 Dec 2021

New study suggests most monoclonal antibody treatments are ineffective against Omicron SARS-CoV-2 variant

The arrival of the Omicron (B.1.1.529) variant has brought into question the effectiveness of current COVID-19 treatments in preventing infection and death. New research published in the preprint bioRxiv* server suggests the efficacy of most monoclonal antibody treatments are ineffective against Omicron.

20 Dec 2021

Humanized mice reveals why few COVID-19 cases are more severe than others

Why do 80 to 90% of people infected with COVID-19 experience only mild cases while 10 to 20% face more severe or life-threatening symptoms?

20 Dec 2021

A new approach for drugs to be more effective against inflammatory bowel disease

Biomedical scientists at the University of California, Riverside, propose a way for drugs to be more effective against inflammatory bowel disease, or IBD, in which the intestine undergoes inflammation.

18 Dec 2021

Seda announces £4m investment in new state-of-the-art facilities

With huge growth in demand for its services, Seda has acquired a new property and is on track to double its annual turnover to at least £7m in the next two years.

From Seda Pharmaceutical Development Services 17 Dec 2021

Services to accelerate genome editing research

AMSBIO has expanded its range of custom gene editing services to complement its extensive portfolio of off-the-shelf CRISPR/Cas9 products.

From AMS Biotechnology 17 Dec 2021

Using fungal vaccine to train stem cells and enhance immune response to infections

The research group Immunology of Fungal Infections at the University of Valencia (UV) has investigated a fungal vaccine with which to train stem cells and hematopoietic progenitors (which produce all the cells of the blood and lifelong immune system) to improve the immune response to infections. The work has been published in the journal Frontiers in Immunology.

16 Dec 2021

Biotechnology News and Research

New strategy to create a cheap and rapid COVID-19 test based on isothermal amplification

Researchers discover antibodies that neutralize omicron and other SARS-CoV-2 variants

Strains - not species - of gut bacteria may provide better insights into the microbiome

Ad5-nCoV vaccine safe and effective against symptomatic, severe COVID-19, trials shows

Cheap and accessible methods for genome sequencing will help tackle future pandemics

Study analyzes the role of circular RNA in ALS pathology

New study suggests most monoclonal antibody treatments are ineffective against Omicron SARS-CoV-2 variant

Humanized mice reveals why few COVID-19 cases are more severe than others

A new approach for drugs to be more effective against inflammatory bowel disease

Seda announces £4m investment in new state-of-the-art facilities

Services to accelerate genome editing research

Using fungal vaccine to train stem cells and enhance immune response to infections

Combination of gallic acid and stretching decreases arthritis inflammation markers in the cells

Providing quick & efficient CRO services with Sino Biological

Depixus Raises EUR 30.6M (USD 35.4M) in Series A Financing

New drug combination may prevent GvHD after stem cell transplantation for blood cancers

UEA researchers reveal how immune cells use the body’s fat stores to fight infection

High quality products for cultured meat research

Report outlines multiple approaches to enhancing resilience in the UK food system

ORF10 protein mutations alter SARS-CoV-2 pathogenicity

Biotechnology eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News